| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315037A1 Methods and compositions for inhibiting tumor cell growth |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926156A2 Vector comprising Mycobacterium tuberculosis 38 kDa antigen for neoplasm treatment |
| 06/30/1999 | EP0926155A2 Polypeptides from the N-terminal domain of gp116 of cytomegalovirus and their diagnostic, prophylactic and therapeutic use |
| 06/30/1999 | EP0925503A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 06/30/1999 | EP0925502A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0925073A1 $i(STAPHYLOCOCCUS AUREUS) ANTIGEN |
| 06/30/1999 | EP0925059A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
| 06/30/1999 | CN1221451A Vaccine containing peroxiredoxin and/or 'beta'-tubulin |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221428A Cellular internalization of PIGR large biological molecule characteristic high structure and associated ligands |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221348A Immunogenic complex, use and method of preparation thereof and vaccine containing same |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/29/1999 | US5917021 Stabilized monomeric protein compositions |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |
| 06/29/1999 | US5916879 Administering to the avian an effective amount of a vector comprising dna transcription unit that comprises a nucleic acid operatively linked to a dna promotr such as cytomegavirus or beta-actin |
| 06/29/1999 | US5916803 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 06/29/1999 | US5916772 The dna encoding saporin and dna encoding the n-terminal extension are selected such that saporin-containing protein is cytotoxic upon internalization by selected cells. |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916768 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916754 Detecting infection |
| 06/29/1999 | US5916588 Dosage forms |
| 06/29/1999 | US5916572 Chagas' disease |
| 06/29/1999 | US5916571 Cleaving a streptococcus pneumoniae serotype 8-polysaccharide into oligosaccharides to preserve immunogenic epitopes, separating above oligosaccharides based on size, selecting oligosaccharide which conatins antigen, mixing with antigen |
| 06/29/1999 | US5916570 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 06/29/1999 | US5916563 Parvovirus protein presenting capsids |
| 06/29/1999 | US5916562 A conjugate molecule, consisting of a synthetic peptide having amino acid sequence with is either n-terminal amino acid residues 1 to 14 or c-terminal 314 to 341 of p2 outer membrane protein of strain of haemophilus influenza type b |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 06/29/1999 | US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/29/1999 | CA1340617C Expression of hepatitis b s and pres2 protiens in methylotrophic yeasts |
| 06/29/1999 | CA1340610C Monoclonal antibody to polymorphic hla determinant-b27 |
| 06/24/1999 | WO1999031279A1 A serological assay for herpes |
| 06/24/1999 | WO1999031257A2 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | WO1999031250A2 Constitutive expression of non-infectious hiv-like particles |
| 06/24/1999 | WO1999031249A1 Nucleic acids encoding hev structural proteins, hev structural proteins encoded thereby and uses thereof |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | WO1999031245A1 Epithelial cell binding proteins obtainable from group b streptococcal strain and encoding dna |
| 06/24/1999 | WO1999031239A1 HUMAN Nap1 PROTEIN |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031133A1 Novel abc transporter |
| 06/24/1999 | WO1999031132A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030737A1 Use of microparticles combined with submicron oil-in-water emulsions |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030734A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030725A1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 06/24/1999 | WO1999030700A1 Immunoglobulin-rich milk, production and use thereof |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1999015692A3 Dengue virus antigens and treatment of dengue fever |
| 06/24/1999 | WO1998043668A9 Attenuated respiratory syncytial virus |
| 06/24/1999 | WO1997030158A9 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/24/1999 | DE19757301A1 Intra-nasal vaccine against yellow fever |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2635158A1 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2315527A1 Human phosphatases |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2314909A1 Human nap1 protein |
| 06/24/1999 | CA2314407A1 Immunoglobulin-rich milk, production and use thereof |
| 06/24/1999 | CA2314319A1 Novel surface protein of neisseria meningitidis |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | CA2309765A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/23/1999 | EP0924298A1 Protein expression in baculovirus vector expression systems |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 06/23/1999 | EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 06/23/1999 | EP0923940A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923605A1 Conjugated mucin peptide vaccines |
| 06/23/1999 | EP0923602A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 06/23/1999 | EP0923284A1 Cellular immunogens useful as cancer vaccines |
| 06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
| 06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
| 06/23/1999 | EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/23/1999 | EP0496818B1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |